✦ LIBER ✦

Tumor hormone receptor status and recurrences in premenopausal node negative breast carcinoma

✍ Scribed by Sally K. Moot; George N. Peters; J. Harold Cheek

Publisher: John Wiley and Sons
Year: 1987
Tongue: English
Weight: 353 KB
Volume: 60
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19870801)60:3<382::aid-cncr2820600316>3.0.co;2-j

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumor hormone receptor status and recurr

Tumor hormone receptor status and recurrences in premenopausal patients with node-negative breast carcinoma

✍ Theodore N. Tsangaris; Sally M. Knox; J. Harold Cheek 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 391 KB 👁 2 views

To ascertain the prognostic significance of tumor hormone receptor status in premenopausal patients with node-negative breast cancer, a retrospective review of 199 patients who met these criteria was conducted. Of these 199 patients, estrogen receptor (ER) data were available for 147. One hundred fo

Laminin receptor in lymph node negative

Laminin receptor in lymph node negative breast carcinoma

✍ Mehrdad Nadji; Mehdi Nassiri; Manuel Fresno; Edward Terzian; Azorides R. Morales 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 1 views

## Background: Expression of 67 kd laminin binding protein, 67lr, is reported to be associated with invasive and metastatic phenotypes in several types of human malignancies. in mammary carcinomas, however, the biologic role of 67lr has been less clear. the authors explored the potential biologic s

Correlation between p53, c-erbB-2, and t

Correlation between p53, c-erbB-2, and topoisomerase II? expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications

✍ Rudolph, Pierre; Olsson, H�kan; Bonatz, Gabriele; Ratjen, Virgo; Bolte, Hendrik; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 402 KB 👁 2 views

Various new prognostic indicators have been identified for mammary carcinomas, but the issue of their significance remains unsettled. The prognostic impact of p53, c-erbB-2, and topoisomerase II alpha expression was investigated in relation to standard prognostic factors for carcinomas of the breast

Survival of premenopausal breast carcino

Survival of premenopausal breast carcinoma patients in relation to menstrual cycle timing of surgery and estrogen receptor/progesterone receptor status of the primary tumor

✍ Lucienne S. Cooper; Cheryl E. Gillett; Neera K. Patel; Diana M. Barnes; Ian S. F 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 2 views

## BACKGROUND. Premenopausal breast carcinoma patients who undergo tumor excision during the follicular phase of their menstrual cycle may have a significantly worse prognosis than those whose tumors are excised in other phases of the menstrual cycle. ## METHODS. Outcome was determined in a ser

Prognostic value of DNA cytometry in 281

Prognostic value of DNA cytometry in 281 premenopausal patients with lymph node negative breast carcinoma randomized in a control trial : Multivariate analysis with Ki-67 index, mitotic count, and microvessel density

✍ Anne Marie Mandard; Yves Denoux; Paulette Herlin; Françoise Duigou; Marc J. van 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 2 views